The FDA in America have approved Ritlecitinib for the treatment of severe alopecia areata (AA). This is an addition to Baricitinib which was approved a year ago by the FDA for the same condition (severe AA). These drugs act as JAK inhibitors (Janus kinase). The FDA approved dose for Ritlecitinib is 50mg once a day … Read more
A South Korean company released a new product in Europe that uses siRNA (small interfering RNA) technology to address hair loss at the genetic level. It claims to targets a protein called the androgen receptor, which binds together androgens at the hair follicle. RNA codes for proteins in the cells and the claim is that … Read more